CES1 and cancer: The impact of CES1 on the sensitivity of HNSCC to cisplatin remains not completely understood, with a complex mechanism involving changes in cancer stem cell phenotype, epithelial-mesenchymal transition, drug efflux, autophagy, and metabolic reprogramming [39].